Osteoarthritis (OA) is a condition that affects millions of people around the world, and it’s only expected to get worse. In fact, a recent study shows that about 15% of people over the age of 30 are already living with OA. By 2050, nearly 1 billion people could be dealing with this painful and limiting condition, making it one of the top causes of disability globally.
One option for managing the symptoms of knee OA is Hymovis, a viscosupplement that injects hyaluronic acid directly into the knee joint. This helps improve joint lubrication and cushioning, making it easier to move and reducing the discomfort that comes with osteoarthritis.
In this article, we’ll take a closer look at Hymovis knee injections, how they work, and what you should consider if you’re thinking about this treatment for your knee pain.
Key Takeaways
- Hymovis is an injectable treatment designed to manage knee osteoarthritis by improving joint lubrication and reducing pain. Its primary ingredient, hyaluronic acid, replenishes joint fluid, making movement smoother and less painful.
- Hymovis is a non-surgical option for patients with mild to moderate knee osteoarthritis, particularly those who haven’t found relief through other treatments like physical therapy or pain medications.
- Clinical studies show that Hymovis can reduce pain by up to 57% at rest and 47% during movement. The treatment’s effects can last for up to six months.
- The standard treatment involves two injections, spaced one week apart, administered by a healthcare professional.
- Side effects are typically mild, including localized pain, swelling, or redness. Rare cases of allergic reactions or joint infections may occur.
About: Medical Spa RX provides medical practices with premium products at the best prices. If you’re looking to buy Hymovis for your practice, the sales representatives at Medical Spa RX can give you guidance.
What is Hymovis Knee Injection?
Hymovis is a knee injection designed to help people with osteoarthritis manage their pain. Its key ingredient, hyaluronic acid, is something your body already makes to keep your joints lubricated and cushioned. But when you have osteoarthritis, your body might not produce enough of it, making your joints stiff and painful.
By injecting Hymovis directly into the knee, it replenishes the hyaluronan that may be missing, helping the joint move more smoothly and with less discomfort. It doesn’t just provide quick relief; it’s designed to offer long-lasting effects, with pain relief lasting up to six months.
For people who haven’t found success with other treatments, Hymovis is a great option for managing knee pain over the long term.
Effectiveness of Hymovis for Osteoarthritis
Studies on Hymovis have shown encouraging results in helping manage osteoarthritis pain. One key clinical trial reported a 34% reduction in WOMAC/VAS pain scores at six months. A post-market trial backed this up, showing a 37% decrease in pain scores. In real-world settings, retrospective studies saw even more significant pain relief, with a 57% reduction at rest and 47% less pain during movement.
These findings suggest that Hymovis can make a real difference for people with knee osteoarthritis, particularly those who haven’t found relief through more conservative treatments.
Considerations for Medical Professionals
When determining whether Hymovis knee injections are the right fit for a patient with osteoarthritis (OA), medical professionals need to carefully assess several factors. The ideal candidates for Hymovis are patients with mild to moderate knee OA who haven’t responded adequately to treatments like pain medications or physical therapy.
For these individuals, Hymovis can offer better joint lubrication and reduced pain during movement, making it a good non-surgical option. However, it’s crucial to rule out any contraindications, such as allergies to hyaluronic acid or infections in the knee joint or surrounding skin.
Potential Side Effects and Contraindications
While Hymovis is generally well-tolerated, there are some potential side effects to consider. Patients may experience swelling, redness, pain, or stiffness at the injection site. These effects are usually temporary but should be discussed with the patient before treatment.
Contraindications include patients with known hypersensitivity to hyaluronic acid or any of the components in Hymovis. Additionally, it should not be used in individuals with skin infections or joint infections in the treated area. As with any intra-articular injection, the risk of infection is present, so strict aseptic techniques must be followed.
To get the best results, Hymovis dosing involves a series of two injections, given one week apart. This timing allows the hyaluronic acid to integrate into the joint, providing up to six months of pain relief. However, for long-term improvement, Hymovis should be used alongside other OA management strategies, such as physical therapy and weight management.
Conclusion
Hymovis knee injections offer a promising solution for managing osteoarthritis (OA), with studies supporting their ability to reduce pain and improve joint function for up to six months. They can be especially beneficial for patients who have had no success with other treatments.
For many individuals living with knee OA, Hymovis provides a real chance to regain comfort and mobility, offering a meaningful improvement in their quality of life.
FAQs
1. What is Hymovis knee injection?
Hymovis is an injectable treatment used to ease the pain and discomfort of osteoarthritis, commonly known as OA.
2. How does Hymovis work for OA?
Hymovis works by replacing or supplementing the natural fluids in your knee joint that may have been reduced due to OA. It helps to reduce friction and improve mobility.
3. Is Hymovis effective for treating OA?
Many patients report significant relief from their OA symptoms after receiving Hymovis injections. However, discussing with your doctor whether this treatment is appropriate for you is essential.
4. Are there any side effects of using Hymovis?
Some people might experience minor side effects, such as swelling or discomfort at the injection site after using Hymovis. If these symptoms persist or worsen, seeking medical attention is crucial.
References
ScienceDaily. (2023, August 21). The newly discovered cell signaling process reveals critical players in the immune response. Retrieved October 11, 2024, from https://www.sciencedaily.com/releases/2023/08/230821232429.htm
Migliore, A., Frediani, B., Gigliucci, G., Foti, C., Crimaldi, S., De Lucia, O., & Iolascon, G. (2020). Efficacy of a Single Intra-Articular HYMOVIS ONE Injection for Managing Symptomatic Hip Osteoarthritis: A 12-Month Follow-Up Retrospective Analysis of the ANTIAGE Register Data. Orthopedic research and reviews, 12, 19–26. https://doi.org/10.2147/ORR.S239355
